Bunkerhill Health raises $25M Series B for hospital AI agents
Bunkerhill Health closed $25M Series B led by Khosla Ventures (Sequoia, Felicis, Optum Ventures, YC participating); total $55M; Carebricks platform pairs operational agents with nine FDA-cleared clinical algorithms across 15 health systems;
On 2026-07-16, the verified AI news record added a significant robotics, science & health development: Bunkerhill Health closed $25M Series B led by Khosla Ventures (Sequoia, Felicis, Optum Ventures, YC participating); total $55M; Carebricks platform pairs operational agents with nine FDA-cleared clinical algorithms across 15 health systems; UTMB runs 22 agents.
Context
Bunkerhill Health closed $25M Series B led by Khosla Ventures (Sequoia, Felicis, Optum Ventures, YC participating); total $55M; Carebricks platform pairs operational agents with nine FDA-cleared clinical algorithms across 15 health systems; UTMB runs 22 agents. Deployment-depth evidence ("22 agents at UTMB") distinguishes it from logo-slide health-AI vendors.
What changed
Bunkerhill Health closed $25M Series B led by Khosla Ventures (Sequoia, Felicis, Optum Ventures, YC participating); total $55M; Carebricks platform pairs operational agents with nine FDA-cleared clinical algorithms across 15 health systems; UTMB runs 22 agents. According to aiweekly.co, the supporting record states: “Its Carebricks platform bundles operational agents with nine FDA-cleared clinical algorithms across 15 health systems… Cleveland Clinic, Mayo Clinic and UTMB are among users; UTMB alone has 22 Bunkerhill agents deployed.”.
Why it matters
Deployment-depth evidence ("22 agents at UTMB") distinguishes it from logo-slide health-AI vendors. The applied-AI angle matters because physical and scientific deployments test whether models can produce reliable outcomes outside chat and coding environments.
Details
The research file records the item under “Bunkerhill Health raises $25M Series B for hospital AI agents” with source timing of Jul 16–17, 2026. The captured research confidence note is: High. Deployment-depth evidence ("22 agents at UTMB") distinguishes it from logo-slide health-AI vendors.
Limitations and caveats
The research file did not identify a blocking caveat, but vendor-supplied claims should still be read as company statements unless independently confirmed.
Sources
Update note: Last reviewed 2026-07-22. Next checkpoint: monitor official channels and the linked source record.
Sources
- aiweekly.co — aggregator
Drafted with AI assistance from source briefs; reviewed for citation completeness and label accuracy.